Mavengity Expands into B2B Research
Owner Marko Pargo Ivanov is now writing the B2B Research desk directly, turning Forrester and Gartner category reports into plain-English breakdowns for buyers.
Read the ArticleThe benchmark Treasury yield crossed 5% intraday for the first time since 2023, with the market pricing a rate increase at this week's Fed meeting after inflation held near 3.4% and oil jumped.
Twenty-two states and a coalition of cities sued to block the green-card benefits rule four days before it takes effect, arguing its undefined scope forces immigrant families to drop programs they legally use.
The FDA approved Scholar Rock's Isembyld, the first therapy for spinal muscular atrophy that acts on the muscle itself, as an add-on to the neuron-targeting drugs patients already take.
AstraZeneca's camizestrant missed its primary endpoint in the first-line SERENA-4 trial, the second oral SERD to fail that setting, while its approved ESR1-mutation indication stands.
X Corp and SpaceXAI moved to dismiss their claims against Apple with prejudice, disclosing no terms, while the same Texas lawsuit against the OpenAI entities continues.
Apollo Global is in talks to acquire J&J's DePuy Synthes unit for close to $20 billion, a year after the company announced it would separate the business as an independent company.
Judge Carl Nichols, a Trump appointee, enjoined the Postal Service's ballot-mail rule in its entirety, finding it beyond the agency's statutory powers, with a Supreme Court application still pending.
The administration says nearly a million unsubsidized marketplace enrollees in 30 states will get $500 checks in October, drawn from a surplus of HealthCare.gov user fees whose spending authority is unresolved.
The Fifth Circuit, sitting en banc, dismissed the Jackson water lawsuit 10-5 and split openly with the Sixth Circuit's Flint rulings over what the Fourteenth Amendment protects.
Non-English intent signal is still under twenty percent of total volume industrywide, which means most platforms are seeing a fraction of the buying activity happening outside English language markets.
One vendor is explicitly competing on restraint, arguing that a plausible AI generated article that is subtly wrong is worse for a knowledge base than no article at all.
Forrester's own buyer guidance undercuts the AI pitch: providers are getting measurably more efficient, and there is little evidence yet that any of that efficiency is reaching customer pricing.
Forrester's guidance to buyers is blunt: having a data centre in the EU answers one sovereignty question out of four, and most vendor pitches stop at the first.
Forrester frames 2026's binding constraint as a workforce that cannot be trained fast enough, which makes this a services category built around people more than platforms.
Generative AI should have commoditized this category, and instead Forrester's criteria count kept climbing, because the moat was always licensed source access, not summarization.
Two of the category's most prominent independent players are now owned by the card networks they were supposed to route around.
Forrester's provider count nearly doubled in three years, and every other technology category in this series points at the same root cause: the software works and the organisation does not change.
Every reference customer for one vendor said they would buy again, which in PLM can mean genuine excellence or a customer base that has nowhere else to go once the evidence chain is built.
Owner Marko Pargo Ivanov is now writing the B2B Research desk directly, turning Forrester and Gartner category reports into plain-English breakdowns for buyers.
Read the ArticleWith James now writing full time for our Healthcare & Medical desk, Mavengity has formally expanded into dedicated medical authorship.
Read the ArticleEvery article on Mavengity is written by a dedicated topic desk and checked against current market practice.
Home, auto, life, and health coverage, explained clearly and checked against the fine print.
Browse InsuranceRates, refinancing, and first-time buyer strategy, without the jargon lenders assume you already know.
Browse MortgageBudgeting, saving, and everyday money habits that compound. No get-rich-quick promises.
Browse Personal FinanceContracts, consumer rights, and disputes, explained so you know where you stand.
Browse LegalHealth coverage and medical billing, broken down so surprise bills are less likely to surprise you.
Browse HealthcareGartner and Forrester categories for B2B, translated into plain-English analysis for buyers, not analyst-subscription holders.
Browse ResearchWe start from public rate filings, regulator guidance, and lender disclosures, not marketing copy.
If a term needs a footnote, we explain it in the sentence instead of hiding it in the fine print.
We flag trade-offs and blind spots, not just the upside, so you get the full picture before you decide.
Mavengity is reader-supported and editorially independent from the products we cover.